The Lab Rats

The group is developing novel immunotherapies using the Adeno-associated virus (AAV) gene-therapy platform that are capable of not only preventing development of disease, but can also stop preexisting (reverse) disease in mouse models of Multiple Sclerosis.

PRINCIPAL INVESTIGATOR

Brad Hoffman

Dr. Hoffman is an Associate Professor and cellular immunologist with a major interest in immune modulation and tolerance induction using adeno-associated virus (AAV) gene therapy. Dr. Hoffman earned his Ph.D. in Immunology from Temple University School of Medicine in 2006. He subsequently performed postdoctoral research in gene therapy at University of Florida.

Brad Hoffman

UF Pediatric News

UF Health pediatric expert answers questions about COVID-19 booster shots for kids ages 12-15

As cases of the omicron variant continue to surge, two federal agencies have approved booster shots of the Pfizer-BioNTech COVID-19 vaccine for 12- to 15-year-old children.  Sonja A. Rasmussen, M.D.,…

Take these steps to protect Florida’s children against COVID-19

As chairs of pediatrics in Florida’s medical schools, we are unified in our fight to protect Florida’s children against COVID-19 infections, hospitalizations, deaths and long-term sequelae.

Covid Vaccine Booster Shots Are Here for Kids Ages 12 and Up — Here’s What Parents Need to Know Right Now

Dr. Sonja Rasmussen, a pediatrics and epidemiology professor at the University of Florida College of Medicine and College of Public Health, says parents need to get their children better masks.

Reghan’s Story: How a Turner syndrome diagnosis led to new career goal

Sixteen-year-old Reghan Dukes longed for answers. She was only 4 foot, 5 inches tall, and she had never had a menstrual cycle. Her mom was concerned, and after a few…